This warning letter, issued on May 18, 2021, addresses concerns about this company’s marketing of kratom and other pharmaceutical and nutritional supplement products. The letter outlines specific violations observed, including problems with claims and marketing of these products. It emphasizes the importance of adherence to regulatory requirements and internal guidelines. The letter serves as a formal notification, providing the recipient with an opportunity to rectify the issues outlined and comply with organizational standards. A timeline for corrective actions is stipulated, along with potential consequences for continued non-compliance.

For further reading:

https://kri.org/wp-content/uploads/2024/10/Umbrella-Warning-Letter-05_18_2021.pdf